# Warrior Met Coal, Inc.: financial statements, quarterly

HCC · NYSE · CIK 1691303 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hcc.md) · [Financials](/companies/hcc/financials.md) · [Filings](/companies/hcc/filings.md) · [Insiders](/companies/hcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [423](/filings/0001691303-24-000037.md) | [364 d](/filings/0001193125-26-048914.md) | [504](/filings/0001691303-25-000022.md) | [397](/filings/0001691303-25-000035.md) | [328](/filings/0001193125-25-267117.md) | [297 d](/filings/0001193125-26-048914.md) | [300](/filings/0001193125-26-197606.md) | [298](/filings/0001193125-26-335324.md) | [329](/filings/0001193125-25-267117.md) | [384 d](/filings/0001193125-26-048914.md) | [459](/filings/0001193125-26-197606.md) | [510](/filings/0001193125-26-335324.md) |
| Cost of revenue | $m | [260](/filings/0001691303-24-000037.md) | [187 d](/filings/0001193125-26-048914.md) | [286](/filings/0001691303-25-000022.md) | [261](/filings/0001691303-25-000035.md) | [232](/filings/0001193125-25-267117.md) | [229 d](/filings/0001193125-26-048914.md) | [246](/filings/0001193125-26-197606.md) | [226](/filings/0001193125-26-335324.md) | [240](/filings/0001193125-25-267117.md) | [271 d](/filings/0001193125-26-048914.md) | [290](/filings/0001193125-26-197606.md) | [340](/filings/0001193125-26-335324.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [11.1](/filings/0001691303-24-000037.md) | [13.0 d](/filings/0001193125-26-048914.md) | [18.9](/filings/0001691303-25-000022.md) | [15.5](/filings/0001691303-25-000035.md) | [11.5](/filings/0001193125-25-267117.md) | [17.2 d](/filings/0001193125-26-048914.md) | [18.4](/filings/0001193125-26-197606.md) | [11.9](/filings/0001193125-26-335324.md) | [17.2](/filings/0001193125-25-267117.md) | [18.1 d](/filings/0001193125-26-048914.md) | [28.2](/filings/0001193125-26-197606.md) | [9.8](/filings/0001193125-26-335324.md) |
| Operating income | $m | [108](/filings/0001691303-24-000037.md) | [134 d](/filings/0001193125-26-048914.md) | [149](/filings/0001691303-25-000022.md) | [70.9](/filings/0001691303-25-000035.md) | [39.1](/filings/0001193125-25-267117.md) | [(4.2) d](/filings/0001193125-26-048914.md) | [(17.4)](/filings/0001193125-26-197606.md) | [7.7](/filings/0001193125-26-335324.md) | [20.7](/filings/0001193125-25-267117.md) | [34.6 d](/filings/0001193125-26-048914.md) | [79.4](/filings/0001193125-26-197606.md) | [94.5](/filings/0001193125-26-335324.md) |
| Interest expense | $m | [3.4](/filings/0001691303-24-000037.md) | [1.6 d](/filings/0001193125-26-048914.md) | [1.1](/filings/0001691303-24-000015.md) | [0.9](/filings/0001691303-25-000035.md) | [1.4](/filings/0001193125-25-267117.md) | [0.8 d](/filings/0001193125-26-048914.md) | [2.1](/filings/0001193125-26-197606.md) | [2.9](/filings/0001193125-26-335324.md) | [2.3](/filings/0001193125-25-267117.md) | [2.4 d](/filings/0001193125-26-048914.md) | [3.2](/filings/0001193125-26-197606.md) | [5.5](/filings/0001193125-26-335324.md) |
| Income tax | $m | [16.8](/filings/0001691303-24-000037.md) | [12.4 d](/filings/0001193125-26-048914.md) | [19.1](/filings/0001691303-25-000022.md) | [8.5](/filings/0001691303-25-000035.md) | [4.6](/filings/0001193125-25-267117.md) | [0.8 d](/filings/0001193125-26-048914.md) | [(6.0)](/filings/0001193125-26-197606.md) | [4.3](/filings/0001193125-26-335324.md) | [(13.7)](/filings/0001193125-25-267117.md) | [12.9 d](/filings/0001193125-26-048914.md) | [6.4](/filings/0001193125-26-197606.md) | [3.7](/filings/0001193125-26-335324.md) |
| Net income | $m | [85.4](/filings/0001691303-24-000037.md) | [129 d](/filings/0001193125-26-048914.md) | [137](/filings/0001691303-25-000022.md) | [70.7](/filings/0001691303-25-000035.md) | [41.8](/filings/0001193125-25-267117.md) | [1.1 d](/filings/0001193125-26-048914.md) | [(8.2)](/filings/0001193125-26-197606.md) | [5.6](/filings/0001193125-26-335324.md) | [36.6](/filings/0001193125-25-267117.md) | [23.0 d](/filings/0001193125-26-048914.md) | [72.3](/filings/0001193125-26-197606.md) | [87.4](/filings/0001193125-26-335324.md) |
| Diluted EPS | $ per share | [1.64](/filings/0001691303-24-000037.md) | not reported | [2.62](/filings/0001691303-25-000022.md) | [1.35](/filings/0001691303-25-000035.md) | [0.80](/filings/0001193125-25-267117.md) | not reported | [(0.16)](/filings/0001193125-26-197606.md) | [0.11](/filings/0001193125-26-335324.md) | [0.70](/filings/0001193125-25-267117.md) | not reported | [1.37](/filings/0001193125-26-197606.md) | [1.65](/filings/0001193125-26-335324.md) |
| Basic EPS | $ per share | [1.64](/filings/0001691303-24-000037.md) | not reported | [2.63](/filings/0001691303-25-000022.md) | [1.35](/filings/0001691303-25-000035.md) | [0.80](/filings/0001193125-25-267117.md) | not reported | [(0.16)](/filings/0001193125-26-197606.md) | [0.11](/filings/0001193125-26-335324.md) | [0.70](/filings/0001193125-25-267117.md) | not reported | [1.37](/filings/0001193125-26-197606.md) | [1.65](/filings/0001193125-26-335324.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [687](/filings/0001691303-24-000037.md) | [738](/filings/0001193125-26-048914.md) | [694](/filings/0001691303-25-000022.md) | [709](/filings/0001691303-25-000035.md) | [583](/filings/0001193125-25-267117.md) | [492](/filings/0001193125-26-335324.md) | [455](/filings/0001193125-26-197606.md) | [383](/filings/0001193125-26-335324.md) | [336](/filings/0001193125-25-267117.md) | [300](/filings/0001193125-26-335324.md) | [203](/filings/0001193125-26-197606.md) | [302](/filings/0001193125-26-335324.md) |
| Current assets | $m | [1,104](/filings/0001691303-23-000039.md) | [1,069](/filings/0001691303-25-000010.md) | [1,119](/filings/0001691303-24-000015.md) | [1,110](/filings/0001691303-24-000022.md) | [972](/filings/0001691303-24-000037.md) | [887](/filings/0001193125-26-048914.md) | [896](/filings/0001691303-25-000022.md) | [853](/filings/0001691303-25-000035.md) | [802](/filings/0001193125-25-267117.md) | [820](/filings/0001193125-26-335324.md) | [828](/filings/0001193125-26-197606.md) | [918](/filings/0001193125-26-335324.md) |
| Total assets | $m | [2,219](/filings/0001691303-23-000039.md) | [2,357](/filings/0001691303-25-000010.md) | [2,479](/filings/0001691303-25-000022.md) | [2,561](/filings/0001691303-25-000035.md) | [2,580](/filings/0001691303-24-000037.md) | [2,592](/filings/0001193125-26-048914.md) | [2,624](/filings/0001691303-25-000022.md) | [2,645](/filings/0001691303-25-000035.md) | [2,683](/filings/0001193125-25-267117.md) | [2,784](/filings/0001193125-26-335324.md) | [2,824](/filings/0001193125-26-197606.md) | [2,900](/filings/0001193125-26-335324.md) |
| Current liabilities | $m | [144](/filings/0001691303-23-000039.md) | [148](/filings/0001691303-25-000010.md) | [163](/filings/0001691303-24-000015.md) | [174](/filings/0001691303-24-000022.md) | [167](/filings/0001691303-24-000037.md) | [170](/filings/0001193125-26-048914.md) | [174](/filings/0001691303-25-000022.md) | [186](/filings/0001691303-25-000035.md) | [194](/filings/0001193125-25-267117.md) | [257](/filings/0001193125-26-335324.md) | [238](/filings/0001193125-26-197606.md) | [234](/filings/0001193125-26-335324.md) |
| Total liabilities | $m | [474](/filings/0001691303-23-000039.md) | [483](/filings/0001691303-25-000010.md) | [500](/filings/0001691303-24-000015.md) | [512](/filings/0001691303-24-000022.md) | [494](/filings/0001691303-24-000037.md) | [501](/filings/0001193125-26-048914.md) | [547](/filings/0001691303-25-000022.md) | [565](/filings/0001691303-25-000035.md) | [565](/filings/0001193125-25-267117.md) | [642](/filings/0001193125-26-335324.md) | [619](/filings/0001193125-26-197606.md) | [610](/filings/0001193125-26-335324.md) |
| Long-term debt | $m | [153](/filings/0001691303-23-000039.md) | [153](/filings/0001691303-25-000010.md) | [153](/filings/0001691303-24-000015.md) | [153](/filings/0001691303-24-000022.md) | [153](/filings/0001691303-24-000037.md) | [154](/filings/0001193125-26-048914.md) | [154](/filings/0001691303-25-000022.md) | [154](/filings/0001691303-25-000035.md) | [154](/filings/0001193125-25-267117.md) | [154](/filings/0001193125-26-335324.md) | [154](/filings/0001193125-26-197606.md) | [155](/filings/0001193125-26-335324.md) |
| Current portion of debt | $m | [0.0](/filings/0001691303-23-000039.md) | [0.0](/filings/0001691303-25-000010.md) | [0.0](/filings/0001691303-24-000015.md) | [0.0](/filings/0001691303-24-000022.md) | [0.0](/filings/0001691303-24-000037.md) | [0.0](/filings/0001193125-26-048914.md) | [0.0](/filings/0001691303-25-000022.md) | [0.0](/filings/0001691303-25-000035.md) | [0.0](/filings/0001193125-25-267117.md) | [0.0](/filings/0001193125-26-335324.md) | [0.0](/filings/0001193125-26-197606.md) | [0.0](/filings/0001193125-26-335324.md) |
| Shareholders' equity | $m | [1,745](/filings/0001691303-24-000037.md) | [1,874](/filings/0001193125-26-048914.md) | [1,978](/filings/0001691303-25-000022.md) | [2,048](/filings/0001691303-25-000035.md) | [2,087](/filings/0001193125-25-267117.md) | [2,091](/filings/0001193125-26-048914.md) | [2,077](/filings/0001193125-26-197606.md) | [2,080](/filings/0001193125-26-335324.md) | [2,118](/filings/0001193125-25-267117.md) | [2,141](/filings/0001193125-26-335324.md) | [2,205](/filings/0001193125-26-197606.md) | [2,290](/filings/0001193125-26-335324.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [139 d](/filings/0001691303-24-000037.md) | [245 d](/filings/0001193125-26-048914.md) | [104](/filings/0001691303-25-000022.md) | [147 d](/filings/0001691303-25-000035.md) | [62.2 d](/filings/0001193125-25-267117.md) | [54.2 d](/filings/0001193125-26-048914.md) | [10.9](/filings/0001193125-26-197606.md) | [37.5 d](/filings/0001193125-26-335324.md) | [105 d](/filings/0001193125-25-267117.md) | [76.1 d](/filings/0001193125-26-048914.md) | [(11.7)](/filings/0001193125-26-197606.md) | [132 d](/filings/0001193125-26-335324.md) |
| Capital expenditure | $m | [107](/filings/0001691303-23-000039.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [3.7](/filings/0001691303-24-000037.md) | [3.7](/filings/0001691303-24-000037.md) | [30.6](/filings/0001691303-25-000022.md) | [4.2](/filings/0001691303-24-000037.md) | [4.2](/filings/0001691303-24-000037.md) | [3.3 d](/filings/0001193125-26-048914.md) | [5.2](/filings/0001193125-26-197606.md) | [4.2 d](/filings/0001193125-26-335324.md) | [4.2 d](/filings/0001193125-25-267117.md) | [4.2 d](/filings/0001193125-26-048914.md) | [4.7](/filings/0001193125-26-197606.md) | [4.2 d](/filings/0001193125-26-335324.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.7](/filings/0001691303-23-000039.md) | [52.0](/filings/0001691303-24-000015.md) | [52.1](/filings/0001691303-24-000022.md) | [52.1](/filings/0001691303-24-000037.md) | [52.2](/filings/0001691303-25-000022.md) | [52.4](/filings/0001691303-25-000035.md) | [52.4](/filings/0001193125-25-267117.md) | [52.5](/filings/0001193125-26-197606.md) | [52.6](/filings/0001193125-26-335324.md) | [52.7](/filings/0001193125-25-267117.md) | [52.8](/filings/0001193125-26-197606.md) | [52.9](/filings/0001193125-26-335324.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,802,087 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335324.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.